Duke Clinical Research Institute
Durham, North Carolina, 27705, United States
NCT Number: NCT00979264
The objective of this study is to evaluate whether a quarterly feedback, education and performance improvement site-based intervention has a greater impact on quality performance and adherence to evidenced-based guidelines than existing on-demand feedback. This study will use a randomized design to compare changes in quality performance and adherence to selected measures among hospitals using existing on-demand reports and general quality improvement (QI) efforts versus those receiving intensive, targeted QI feedback via reports, teleconferences, webinars, and specialized tool kits.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Durham, North Carolina, 27705, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Personalized performance improvement interventions, including premier site data reports, personalized feedback/teleconferences, comprehensive toolkits, and focused webinars; in addition to other general QI tools typically available through participation in Get With the Guidelines Heart Failure.
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Looking for future studies?
Notify MeDuke University
Other
Acronym: CERTs-HF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07833384
Arterial Occlusive Diseases, Arteriosclerosis
Baton Rouge, Louisiana, United States
View Trial DetailsNCT04591639
Cardiomyopathies, Cardiovascular Diseases
Edinburgh, Scotland, United Kingdom
View Trial DetailsNCT05696522
Arrhythmias, Cardiac, Cardiac Conduction System Disease
London, United Kingdom
View Trial DetailsNCT07390110
Cardiovascular Diseases, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial Details